OGN vs. MRK
Compare and contrast key facts about Organon & Co. (OGN) and Merck & Co., Inc. (MRK).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: OGN or MRK.
Correlation
The correlation between OGN and MRK is 0.17, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
OGN vs. MRK - Performance Comparison
Loading data...
Key characteristics
OGN:
-1.08
MRK:
-1.46
OGN:
-1.59
MRK:
-1.97
OGN:
0.78
MRK:
0.74
OGN:
-0.73
MRK:
-0.90
OGN:
-1.93
MRK:
-1.67
OGN:
28.66%
MRK:
23.41%
OGN:
51.56%
MRK:
27.67%
OGN:
-75.77%
MRK:
-68.62%
OGN:
-72.75%
MRK:
-41.45%
Fundamentals
OGN:
$2.28B
MRK:
$187.83B
OGN:
$3.14
MRK:
$7.00
OGN:
2.79
MRK:
10.69
OGN:
0.36
MRK:
2.94
OGN:
4.21
MRK:
3.89
OGN:
$6.29B
MRK:
$63.92B
OGN:
$3.60B
MRK:
$51.75B
OGN:
$1.50B
MRK:
$27.30B
Returns By Period
In the year-to-date period, OGN achieves a -38.15% return, which is significantly lower than MRK's -22.88% return.
OGN
-38.15%
-16.26%
-38.61%
-55.75%
N/A
N/A
MRK
-22.88%
-0.52%
-19.71%
-40.16%
3.11%
6.00%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
OGN vs. MRK — Risk-Adjusted Performance Rank
OGN
MRK
OGN vs. MRK - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Organon & Co. (OGN) and Merck & Co., Inc. (MRK). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
OGN vs. MRK - Dividend Comparison
OGN's dividend yield for the trailing twelve months is around 9.51%, more than MRK's 4.15% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
OGN Organon & Co. | 9.51% | 7.51% | 7.77% | 4.01% | 1.84% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
MRK Merck & Co., Inc. | 4.15% | 3.14% | 2.72% | 2.52% | 3.41% | 3.03% | 2.48% | 2.60% | 3.36% | 3.14% | 3.43% | 3.12% |
Drawdowns
OGN vs. MRK - Drawdown Comparison
The maximum OGN drawdown since its inception was -75.77%, which is greater than MRK's maximum drawdown of -68.62%. Use the drawdown chart below to compare losses from any high point for OGN and MRK. For additional features, visit the drawdowns tool.
Loading data...
Volatility
OGN vs. MRK - Volatility Comparison
Organon & Co. (OGN) has a higher volatility of 37.83% compared to Merck & Co., Inc. (MRK) at 12.13%. This indicates that OGN's price experiences larger fluctuations and is considered to be riskier than MRK based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
OGN vs. MRK - Financials Comparison
This section allows you to compare key financial metrics between Organon & Co. and Merck & Co., Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
OGN vs. MRK - Profitability Comparison
OGN - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Organon & Co. reported a gross profit of 841.00M and revenue of 1.51B. Therefore, the gross margin over that period was 55.6%.
MRK - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Merck & Co., Inc. reported a gross profit of 12.11B and revenue of 15.53B. Therefore, the gross margin over that period was 78.0%.
OGN - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Organon & Co. reported an operating income of 325.00M and revenue of 1.51B, resulting in an operating margin of 21.5%.
MRK - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Merck & Co., Inc. reported an operating income of 5.94B and revenue of 15.53B, resulting in an operating margin of 38.2%.
OGN - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Organon & Co. reported a net income of 87.00M and revenue of 1.51B, resulting in a net margin of 5.8%.
MRK - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Merck & Co., Inc. reported a net income of 5.08B and revenue of 15.53B, resulting in a net margin of 32.7%.